BOCA RATON, Fla., March 13 /PRNewswire-FirstCall/ -- Nabi
Biopharmaceuticals (Nasdaq: NABI) announced today that Dr. Leslie Hudson,
president and chief executive officer will participate in the Lehman
Brothers Tenth Annual Global Healthcare Conference on Monday, March 19,
2007, at the Loewes Miami Beach Hotel in Miami, Florida. Dr. Hudson will
present a company overview including a review of Nabi's new corporate
strategy at 1:30 p.m. eastern time.
The live webcast can be accessed at:
http://cc.talkpoint.com?LEHM002/031907a_jw/default.asp?entity=Nabi
The webcast presentation will be available through April 19, 2007.
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in
powering the immune system to develop and market products that fight
serious medical conditions. The company has two products on the market
today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM)
(allopurinol sodium) for Injection. Nabi Biopharmaceuticals is focused on
developing products that address unmet medical needs and offer commercial
opportunities in our core business areas: Hepatitis and transplant,
Gram-positive bacterial infections and nicotine addiction. For a complete
list of pipeline products, please go to:
http://www.nabi.com/pipeline/index.php. The company is headquartered in
Boca Raton, Florida. For additional information about Nabi
Biopharmaceuticals, please visit our website at http://www.nabi.com.
SOURCE Nabi Biopharmaceuticals
 back to top
Related links:
http://www.nabi.com
http://www.nabi.com/pipeline/index.php
CONTACT:
Tom Rathjen, Vice President, Investor
Relations of Nabi Biopharmaceuticals, +1-561-989-5800
|
